To investigate the potential role of the PTPRZ1 in tumor development, we leveraged CRISPR/Cas9 to perform knockout experiments in two distinct LUSC cell lines, H520 and HCC95, both characterized by high cellular expression of the gene (Figure S10A–D; Table S1I, Supporting Information). The gene discussed is PTPRZ1; the disease is neoplasm.